MTOR and angiomyolipoma: Beyond that, it has not been investigated how mTOR inhibitor therapy affects the different tissue types of angiomyolipoma, vascularization (angio-), myocytes (-myo-) and lipid cells (-lipoma), during the time-course of therapy.